Tong Xiaolin, the expert in internal medicine of TCM, academician of the Chinese Academy of Sciences, and leader of the key endocrinology discipline of the National Administration of TCM, is the former vice president and professor of Guang'anmen Hospital. He has won the Ho Leung Ho Lee Science and Technology Progress Award, two second-class National Science and Technology Progress Awards, the National Innovation Award Medal, the National Advanced Individual in Fighting COVID-19, and the Most Beautiful Scientific and Technological Worker.
Academician Tong Xiaolin has devoted himself to teaching and research for a long time, reconstructing the TCM diagnosis and treatment system and modern herbal framework, creating state-target differentiation and treatment methods, and building a road of integration of TCM and Western medicine with combinations of disease and syndrome, and macro and micro studies. He systematically constructed the dose-effect theory of prescriptions, innovatively used ancient empirical prescriptions for difficult and complex diseases, and set a model for the modern development of traditional medicine.
During the COVID-19 period, he went to the front line many times, presided over the formulation of the national TCM diagnosis and treatment plan, created the "Wuchang Model" of community prevention and control, and provided a powerful TCM prevention and treatment system plan for the long-term response to new and sudden emergence of major infectious diseases. As the principal investigator, he presided over more than 30 national, provincial, and ministerial projects; edited 26 monographs; published 304 related academic papers, of which 76 were included in SCI; and obtained 24 herbal medicine patents.